More PRNewswire
View Older Stories View Newer Stories-
AMD Bundles Carbice Ice Pad with Ryzen™ 7 5800X3D
-
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherap
-
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
-
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
-
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Builders
-
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
-
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026
-
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026
-
Scripps Pulls 54 Local Stations from DIRECTV After Seeking Record Retransmission Consent Rates
-
Web3 Has No Safe AI. DMind AI Just Quantified the Gap -- and KDD 2026 Made It Official.
-
Cango Inc. Reports First Quarter 2026 Unaudited Financial Results
-
Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
-
Mazda Announces New Zinc Green Color
-
Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
-
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
-
Kulani Kinis Makes Miami Swim Week Debut with "Endless" Runway Experience and SOJOS Eyewear Collaboration
-
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
-
CPKC to maintain rail operations across Canada during IBEW strike
-
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
-
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradi
-
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
-
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annua
-
Miami Retirement Summit 2026 Returns to The Biltmore Featuring Coral Gables Mayor Vince Lago
-
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders
-
SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER
-
Cook County Treasurer Maria Pappas' Historic Property Tax Sale Reform Legislation Passes in Illinois General Assembly
-
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
-
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
-
Alley Cat Allies Continues to Protect the Cats of the Paseo del Morro and Collaborates with Puerto Rico Leaders
-
Guerra Wealth Advisors Invites South Florida Community to Join the St. Jude Walk Miami as a Champion Sponsor
-
AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
-
Tulsa's Route 66 Capital Cruise Sets GUINNESS WORLD RECORDS™ Mark
-
TTW Unveils Top 50 Coolcation Travel Destinations in the World for 2026
-
Cyient Enters Agreement to Acquire TAO Digital
-
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
-
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
-
Ducks Unlimited Completes Historic $4.06 Billion Campaign
-
/C O R R E C T I O N -- Hyundai Motor America/
-
Prostate Health Supplements From PureHealth Research Enhance Bladder Control With Clinical Lycopene
-
Local Action to Protect Our Youth from Nicotine Addiction
-
Real Estate Expert Justus Smith of Keystone Explains Where Real Estate Commission Dollars Go for HelloNation
-
Cupshe Returns to Miami Swim Week 2026 With "The Arrival" at Temple House
-
ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagno
-
Fontana Candle Co. Announces Major U.S. Manufacturing Expansion Scheduled for This Fall
-
How Restoration Expert Brett Swiatek of Buffalo Explains Stained Glass Restoration for HelloNation
-
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
-
University of Phoenix College of Doctoral Studies holds fifth annual colloquium supporting doctoral students
-
The 7th China-CEEC Local Leaders' Meeting and 2026 Shandong International Friendship Cities Cooperation and Exchange Week Successfully Held
-
Shaping the Future Together! What Global Guests Said at the 2026 China-CEEC Local Leaders' Meeting and Shandong Friendship Cities Week
